ZHANG Yong Peng; PENG Xiao Yan; LI Zhi Hua; CHEN Feng Hua

doi:10.3967/0895-3988.2012.03.009

Hyperglycemic Effects of a Periocular Dexamethasone Injection in Diabetic Patients after Vitreoretinal Surgery

ZHANG Yong Peng, PENG Xiao Yan, LI Zhi Hua, CHEN Feng Hua

文章导航 > Biomedical and Environmental Sciences > 2012 > 25(3): 311-316

ZHANG Yong Peng, PENG Xiao Yan, LI Zhi Hua, CHEN Feng Hua. Hyperglycemic Effects of a Periocular Dexamethasone Injection in Diabetic Patients after Vitreoretinal Surgery[J]. Biomedical and Environmental Sciences, 2012, 25(3): 311-316. doi: 10.3967/0895-3988.2012.03.009

Citation:

ZHANG Yong Peng, PENG Xiao Yan, LI Zhi Hua, CHEN Feng Hua. Hyperglycemic Effects of a Periocular Dexamethasone Injection in Diabetic Patients after Vitreoretinal Surgery[J]. Biomedical and Environmental Sciences, 2012, 25(3): 311-316. doi: 10.3967/0895-3988.2012.03.009

doi: 10.3967/0895-3988.2012.03.009

Hyperglycemic Effects of a Periocular Dexamethasone Injection in Diabetic Patients after Vitreoretinal Surgery

Beijing Ophthalmology and Visual Science Laboratory, Beijing Tongren Eye Center, Beijing Tongren Hospital,Capital Medical University, Beijing 100730, China

摘要: Objective To examine the hyperglycemic effects of periocular dexamethasone injection in type 2 diabetic patients after vitreoretinal surgery (VRS).Methods This was a retrospective non-randomized controlled trial.Twenty consecutive hospitalized patients with type 2 diabetes and ocular inflammatory reaction after VRS were enrolled in this study.Ten patients received 2.5 mg dexamethasone and 10 patients received 5 mg dexamethasone.Fourteen consecutive type 2 diabetic patients without ocular inflammatory reaction after VRS were used as control group.We measured fasting blood glucose (FBG) and at 2 h after each meal (post prandial glucose,PBG; 09:00,13:00,and 19:00 h) after periocular dexamethasone injection.Differences among three groups were determined by q tests.Results The PBG levels in both dexamethasone-treated groups started to increase within 5 h after injection (i.e.,PBG at 13:00 h),and were significantly increased at 19:00 h after injection (P＜0.05).BG levels were almost 2-fold higher than at baseline and compared with the control group.The BG values declined gradually by 24 h to 48 h after injection.There were no differences in BG levels between the two dexamethasone-treated groups (P＞0.05),except for PBG at 19:00 h on day 2 after injection (P＜0.05).Conclusion Periocular dexamethasone injection can cause transient hyperglycemia in diabetic patients after VRS.BG monitoring should be performed following such injection.
- /
- /
- /
- /
Abstract: Objective To examine the hyperglycemic effects of periocular dexamethasone injection in type 2 diabetic patients after vitreoretinal surgery (VRS).Methods This was a retrospective non-randomized controlled trial.Twenty consecutive hospitalized patients with type 2 diabetes and ocular inflammatory reaction after VRS were enrolled in this study.Ten patients received 2.5 mg dexamethasone and 10 patients received 5 mg dexamethasone.Fourteen consecutive type 2 diabetic patients without ocular inflammatory reaction after VRS were used as control group.We measured fasting blood glucose (FBG) and at 2 h after each meal (post prandial glucose,PBG; 09:00,13:00,and 19:00 h) after periocular dexamethasone injection.Differences among three groups were determined by q tests.Results The PBG levels in both dexamethasone-treated groups started to increase within 5 h after injection (i.e.,PBG at 13:00 h),and were significantly increased at 19:00 h after injection (P＜0.05).BG levels were almost 2-fold higher than at baseline and compared with the control group.The BG values declined gradually by 24 h to 48 h after injection.There were no differences in BG levels between the two dexamethasone-treated groups (P＞0.05),except for PBG at 19:00 h on day 2 after injection (P＜0.05).Conclusion Periocular dexamethasone injection can cause transient hyperglycemia in diabetic patients after VRS.BG monitoring should be performed following such injection.
- Dexamethasone /
- Periocular injection /
- Vitreoretinal surgery /
- Diabetes mellitus /
- Blood glucose

[1]	Shuanghua Xie, Shuangying Li, Shaofei Su, Enjie Zhang, Shen Gao, Yue Zhang, Jianhui Liu, Minhui Hu, Ruixia Liu, Wentao Yue, Chenghong Yin. Association between ABO Blood Types and the Risk of Gestational Diabetes Mellitus: A Prospective Cohort Study . Biomedical and Environmental Sciences, 2025, 38(6): 678-692. doi: 10.3967/bes2025.046
[2]	Taiyang Luo, Xuan Deng, Xueyu Chen, Yuhe Liu, Shuohua Chen, Haoran Sun, Ziwei Yin, Shouling Wu, Yong Zhou, Xingdong Zheng. Association of Longitudinal Change in Fasting Blood Glucose with Risk of Cerebral Infarction in a Patients with Diabetes . Biomedical and Environmental Sciences, 2025, 38(): 1-9. doi: 10.3967/bes2025.052
[3]	Zhiyuan Ning, Jinglan Zhang, Bingbing Fan, Yanlin Qu, Chang Su, Tao Zhang. Life-Course Trajectories of Body Mass Index, Insulin Resistance, and Incident Diabetes in Chinese Adults . Biomedical and Environmental Sciences, 2025, 38(6): 706-715. doi: 10.3967/bes2025.072
[4]	Monireh Faghir-Ganji, Narjes Abdolmohammadi, Maryam Nikbina, Alireza Amanollahi, Alireza Ansari-Moghaddam, Rozhan Khezri, Hamidreza Baradaran. Prevalence of Anemia in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis . Biomedical and Environmental Sciences, 2024, 37(1): 96-107. doi: 10.3967/bes2024.008
[5]	MAO Yu, GAO Li Qin, JIA Li Yun, HOU Si Meng, XIAO Yuan Yuan, JI Xi Wen, WANG Shuang. Observation of the Curative Effect of the Dexamethasone Vitreous Cavity Implant for the Treatment of Irvine-Gass Syndrome . Biomedical and Environmental Sciences, 2023, 36(8): 725-731. doi: 10.3967/bes2023.084
[6]	XU Lu, YU Shu Qing, GAO Le, HUANG Yi, WU Shan Shan, YANG Jun, SUN Yi Xin, YANG Zhi Rong, CHAI San Bao, ZHANG Yuan, JI Li Nong, SUN Feng, ZHAN Si Yan. Effects of Incretin-based Therapies on Weight-related Indicators among Patients with Type 2 Diabetes: A Network Meta-analysis . Biomedical and Environmental Sciences, 2020, 33(1): 37-47. doi: 10.3967/bes2020.005
[7]	SUN Ru Bao, SHANG Shuai, ZHANG Wei, LIN Ben Cheng, WANG Qiang, SHI Yun, XI Zhu Ge. Endocrine Disruption Activity of 30-day Dietary Exposure to Decabromodiphenyl Ethane in Balb/C Mouse . Biomedical and Environmental Sciences, 2018, 31(1): 12-22. doi: 10.3967/bes2018.002
[8]	ZHUANG Guo Qing, WANG You Xin. A Tiny RNA Molecule with a Big Impact on Type 2 Diabetes Mellitus Susceptibility^* . Biomedical and Environmental Sciences, 2017, 30(11): 855-861. doi: 10.3967/bes2017.116
[9]	MA Yan, HUANG Mai Ling, LI Tao, DU Jian, SHU Wei, XIE Shi Heng, WANG Hong Hong, ZHU Guo Feng, TAN Shou Yong, FU Yan Yong, MA Li Ping, ZHANG Lian Ying, LIU Fei Ying, HU Dai Yu, ZHANG Yan Ling, LI Xiang Qun, LIU Yu Hong, LI Liang. Role of Diabetes Mellitus on Treatment Effects in Drug-susceptible Initial Pulmonary Tuberculosis Patients in China . Biomedical and Environmental Sciences, 2017, 30(9): 671-675. doi: 10.3967/bes2017.089
[10]	CHENG Jun, ZHANG Hui, ZHAO Yan Lin, WANG Li Xia, CHEN Ming Ting. Mutual Impact of Diabetes Mellitus and Tuberculosis in China . Biomedical and Environmental Sciences, 2017, 30(5): 384-389. doi: 10.3967/bes2017.051
[11]	HE Huan, ZHEN Qing, LI Yong, KOU Chang Gui, TAO Yu Chun, WANG Chang, JosepHSam Kanu, LU Yu Ping, YU Ming Xi, ZHANG Hui Ping, YU Ya Qin, LI Bo, LIU Ya Wen. Prevalence of High Non-high-density Lipoprotein Cholesterol and Associated Risk Factors in Patients with Diabetes Mellitus in Jilin Province, China：A Cross-sectional Study . Biomedical and Environmental Sciences, 2016, 29(7): 534-538. doi: 10.3967/bes2016.071
[12]	ZHAOFang, MAYanFen, WENJingXiao, DUYan Fang, LIChunLin, andLIGuangWei. Parsimonious Model for Blood Glucose Level Monitoring in Type 2 Diabetes patients . Biomedical and Environmental Sciences, 2014, 27(7): 559-563. doi: 10.3967/bes2014.086
[13]	MA Hui, GAO Xin, LIN Huan Dong, HU Yu, LI Xiao Ming, GAO Jian, ZHAO Nai Qing. Glycated Haemoglobin in Diagnosis of Diabetes Mellitus and Pre-diabetes among Middle-aged and Elderly Population: Shanghai Changfeng Study . Biomedical and Environmental Sciences, 2013, 26(3): 155-162. doi: 10.3967/0895-3988.2013.03.001
[14]	LI Jiang, JIA Bao Hui, SUN Jian, LOU Xiao Liang, HU Shen Jiang. Phospholamban Antisense RNA Improves SR Ca2+-ATPase Activity and Left Ventricular Function in STZ-induced Diabetic Rats . Biomedical and Environmental Sciences, 2013, 26(7): 577-583. doi: 10.3967/0895-3988.2013.07.009
[15]	CHU Chen, GUI Yong Hao, REN Yun Yun, SHI Li Ye. The Impacts of Maternal Gestational Diabetes Mellitus (GDM) on Fetal Hearts . Biomedical and Environmental Sciences, 2012, 25(1): 15-22. doi: 10.3967/0895-3988.2012.01.003
[16]	ZHONG Yuan, ZHANG Xiao Yan, MIAO Ya, ZHU Jie Hua, YAN Hong, WANG Bei Yun, JIN Jun, HU Ting Jun, JIA Wei Ping. The Relationship between Glucose Excursion and Cognitive Function in Aged Type 2 Diabetes Patients . Biomedical and Environmental Sciences, 2012, 25(1): 1-7. doi: 10.3967/0895-3988.2012.01.001
[17]	MIN YANG, CHANG-CHUN QIU, QUN XU, HONG-DING XIANG. Association of Angiotensin Converting Enzyme Gene I/D Polymorphism With Type 2 Diabetes Mellitus . Biomedical and Environmental Sciences, 2006, 19(4): 323-327.
[18]	XU HONG, TAN SHU_MEI, LI SHU_QING. Effects of Soybean Fibers on Blood Sugar, Lipid Levels and Hepatic_Nephritic Histomorphology in Mice With Diabetes Mellitus . Biomedical and Environmental Sciences, 2001, 14(3): 256-261.
[19]	WANG ZENG-ZHEN, HUANG XU-ZHEN, TANG SI-BIN, CHEN YONG-MEI, CHEN LI-GONG, JIN ZHI-XIN, LUAN XIAO-JUN, ZHANG JIAN-HUA. The Prevalence of NIDDM and IGT and Related Factors Among Residents in Some Areas of Hubei Province, China . Biomedical and Environmental Sciences, 2000, 13(2): 148-153.
[20]	LI XIN-HUA, LI TIAN-LIN, YANG Ze, LIU ZUN-YONG, WEI YI-DA, JIN SHU-XIANG, CHEN HONG, QIN RU-LI, LI Yan-qing, JANICE S.DORMAN, RONALD E.LAPORTE, WANG KE-AN. A Nine-Year Prospective Study on the Incidence of Childhood Type 1 Diabetes Mellitus in China . Biomedical and Environmental Sciences, 2000, 13(4): 263-270.

点击查看大图

计量

文章访问数: 1198
HTML全文浏览量: 449
PDF下载量: 31
被引次数: 0

Hyperglycemic Effects of a Periocular Dexamethasone Injection in Diabetic Patients after Vitreoretinal Surgery

doi: 10.3967/0895-3988.2012.03.009

刊出日期: 2012-06-20

关键词:

Dexamethasone /

Periocular injection /

Vitreoretinal surgery /

Diabetes mellitus /

Blood glucose

摘要: Objective To examine the hyperglycemic effects of periocular dexamethasone injection in type 2 diabetic patients after vitreoretinal surgery (VRS).Methods This was a retrospective non-randomized controlled trial.Twenty consecutive hospitalized patients with type 2 diabetes and ocular inflammatory reaction after VRS were enrolled in this study.Ten patients received 2.5 mg dexamethasone and 10 patients received 5 mg dexamethasone.Fourteen consecutive type 2 diabetic patients without ocular inflammatory reaction after VRS were used as control group.We measured fasting blood glucose (FBG) and at 2 h after each meal (post prandial glucose,PBG; 09:00,13:00,and 19:00 h) after periocular dexamethasone injection.Differences among three groups were determined by q tests.Results The PBG levels in both dexamethasone-treated groups started to increase within 5 h after injection (i.e.,PBG at 13:00 h),and were significantly increased at 19:00 h after injection (P＜0.05).BG levels were almost 2-fold higher than at baseline and compared with the control group.The BG values declined gradually by 24 h to 48 h after injection.There were no differences in BG levels between the two dexamethasone-treated groups (P＞0.05),except for PBG at 19:00 h on day 2 after injection (P＜0.05).Conclusion Periocular dexamethasone injection can cause transient hyperglycemia in diabetic patients after VRS.BG monitoring should be performed following such injection.

English Abstract

Hyperglycemic Effects of a Periocular Dexamethasone Injection in Diabetic Patients after Vitreoretinal Surgery

Beijing Ophthalmology and Visual Science Laboratory, Beijing Tongren Eye Center, Beijing Tongren Hospital,Capital Medical University, Beijing 100730, China

Publish Date: 2012-06-20

Keywords:

Abstract: Objective To examine the hyperglycemic effects of periocular dexamethasone injection in type 2 diabetic patients after vitreoretinal surgery (VRS).Methods This was a retrospective non-randomized controlled trial.Twenty consecutive hospitalized patients with type 2 diabetes and ocular inflammatory reaction after VRS were enrolled in this study.Ten patients received 2.5 mg dexamethasone and 10 patients received 5 mg dexamethasone.Fourteen consecutive type 2 diabetic patients without ocular inflammatory reaction after VRS were used as control group.We measured fasting blood glucose (FBG) and at 2 h after each meal (post prandial glucose,PBG; 09:00,13:00,and 19:00 h) after periocular dexamethasone injection.Differences among three groups were determined by q tests.Results The PBG levels in both dexamethasone-treated groups started to increase within 5 h after injection (i.e.,PBG at 13:00 h),and were significantly increased at 19:00 h after injection (P＜0.05).BG levels were almost 2-fold higher than at baseline and compared with the control group.The BG values declined gradually by 24 h to 48 h after injection.There were no differences in BG levels between the two dexamethasone-treated groups (P＞0.05),except for PBG at 19:00 h on day 2 after injection (P＜0.05).Conclusion Periocular dexamethasone injection can cause transient hyperglycemia in diabetic patients after VRS.BG monitoring should be performed following such injection.

Citation: